[go: up one dir, main page]

NO964451L - X-ray contrast compositions containing pharmaceutically acceptable clays - Google Patents

X-ray contrast compositions containing pharmaceutically acceptable clays

Info

Publication number
NO964451L
NO964451L NO964451A NO964451A NO964451L NO 964451 L NO964451 L NO 964451L NO 964451 A NO964451 A NO 964451A NO 964451 A NO964451 A NO 964451A NO 964451 L NO964451 L NO 964451L
Authority
NO
Norway
Prior art keywords
pharmaceutically acceptable
ray contrast
compositions containing
containing pharmaceutically
contrast compositions
Prior art date
Application number
NO964451A
Other languages
Norwegian (no)
Other versions
NO964451D0 (en
Inventor
Stephen B Ruddy
Gregory L Mcintire
Mary E Roberts
John L Toner
Edward R Bacon
Tom Caufield
Eugene R Cooper
Brent D Douty
Carl R Illig
Kimberly Estep
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/230,580 external-priority patent/US5476646A/en
Priority claimed from US08/236,287 external-priority patent/US5424056A/en
Priority claimed from US08/237,502 external-priority patent/US5492687A/en
Priority claimed from US08/239,090 external-priority patent/US5484585A/en
Priority claimed from US08/247,424 external-priority patent/US5360604A/en
Priority claimed from US08/247,438 external-priority patent/US5531979A/en
Priority claimed from US08/249,424 external-priority patent/US5472682A/en
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of NO964451D0 publication Critical patent/NO964451D0/en
Publication of NO964451L publication Critical patent/NO964451L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0495—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound intended for oral administration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Det er beskrevet røntgenkontrastmidler for oral eller retrograd undersøkelse av tarmkanalen, og hvor nevnte middel inneholder et røntgenkontrastmiddel i kombinasjon med en farmasøytisk akseptabel leire i et farmasøytisk akseptabelt bærestoff, foruten fremgangsmåter for deres anvendelse i diagnostisk radiologi av tarmkanalen.X-ray contrast agents for oral or retrograde examination of the intestinal tract are described, wherein said agent contains an X-ray contrast agent in combination with a pharmaceutically acceptable clay in a pharmaceutically acceptable carrier, as well as methods for their use in diagnostic radiology of the intestinal tract.

NO964451A 1994-04-21 1996-10-18 X-ray contrast compositions containing pharmaceutically acceptable clays NO964451L (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US08/230,580 US5476646A (en) 1992-05-01 1994-04-21 X-ray contrast compositions containing iodophenoxyalkanes and pharmaceutically acceptable clays
US08/236,287 US5424056A (en) 1993-03-01 1994-04-29 X-ray contrast compositions containing iodoaniline derivatives and pharmaceutically acceptable clays
US08/237,502 US5492687A (en) 1993-03-11 1994-05-03 Compositions of iodophenoxy alkylene ethers and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US08/239,090 US5484585A (en) 1993-03-11 1994-05-05 Compositions of iodobenzoic acid derivatives and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US08/247,424 US5360604A (en) 1994-04-14 1994-05-23 X-ray contrast compositions containing an organic crystalline X-ray contrast agent in combination with pharmaceutically acceptable clays
US08/247,438 US5531979A (en) 1993-02-02 1994-05-23 Compositions of iodophenoxy alkanes and iodophenyl ethers and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US08/249,424 US5472682A (en) 1993-03-31 1994-05-26 Compositions of iodophenyl esters and iodophenyl sulfonates and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
PCT/GB1995/000566 WO1995028969A1 (en) 1994-04-21 1995-03-16 X-ray contrast compositions containing pharmaceutically acceptable clays

Publications (2)

Publication Number Publication Date
NO964451D0 NO964451D0 (en) 1996-10-18
NO964451L true NO964451L (en) 1996-12-18

Family

ID=27569393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964451A NO964451L (en) 1994-04-21 1996-10-18 X-ray contrast compositions containing pharmaceutically acceptable clays

Country Status (9)

Country Link
EP (1) EP0756497A1 (en)
JP (1) JPH09512029A (en)
CN (1) CN1147206A (en)
AU (1) AU1897795A (en)
CA (1) CA2187019A1 (en)
FI (1) FI964212A0 (en)
HU (1) HUT76304A (en)
NO (1) NO964451L (en)
WO (1) WO1995028969A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466440A (en) * 1994-12-30 1995-11-14 Eastman Kodak Company Formulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable clays
JP4670229B2 (en) * 2003-06-10 2011-04-13 味の素株式会社 Composition for gastrointestinal imaging in CT colonography
WO2005080320A1 (en) 2004-02-13 2005-09-01 Warner-Lambert Company Llc Androgen receptor modulators
WO2005100305A1 (en) 2004-04-13 2005-10-27 Warner-Lambert Company Llc Androgen modulators
JP2007533726A (en) 2004-04-22 2007-11-22 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー Androgen modulator
MXPA06015169A (en) 2004-07-08 2007-08-21 Warner Lambert Co Androgen modulators.
CN1330380C (en) * 2005-03-18 2007-08-08 山东师范大学 X-ray contrast agent composition and its preparation method
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators
ES2897624T3 (en) 2013-03-15 2022-03-02 Univ California Low-z Atom-Based Enteric CT Contrast Material
WO2015024025A1 (en) 2013-08-16 2015-02-19 The Regents Of The University Of California Silicone-based enteric ct contrast material
CN106075476B (en) * 2016-07-30 2019-05-31 温州市人民医院 A kind of contrast agent

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB767788A (en) * 1953-12-28 1957-02-06 Schering Corp Polyiodinated phenyl fatty acid compounds and process for their manufacture
CH338274A (en) * 1954-01-08 1959-05-15 Schering Corp Use as radiopaque agents of polyiodinated phenoxy fatty acids
CA985626A (en) * 1970-03-10 1976-03-16 E.R. Squibb And Sons Coating composition for moist surface
CA2094893A1 (en) * 1992-05-01 1993-11-02 Carl R. Illig X-ray contrast compositions containing film-forming materials
US5260049A (en) * 1992-05-01 1993-11-09 Sterling Winthrop Inc. X-ray contrast compositions comprising alkoxyphenols
NZ250063A (en) * 1992-12-14 1996-03-26 Eastman Kodak Co Iodinated aromatic acid ester derivatives; x-ray contrast compositions
US5322679A (en) * 1992-12-16 1994-06-21 Sterling Winthrop Inc. Iodinated aroyloxy esters
US5316755A (en) * 1993-02-02 1994-05-31 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers for visualization of the gastrointestinal tract
US5326553A (en) * 1993-02-02 1994-07-05 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers in film-forming materials for visualization of the gastrointestinal tract
US5308607A (en) * 1993-02-04 1994-05-03 Sterling Winthrop Inc. Compositions of alkylbenzenes for visualization of the gastrointestinal tract using X-ray contrast
US5334370A (en) * 1993-02-04 1994-08-02 Sterling Winthrop Inc. Compositions of alkylbenzenes in film-forming materials for visualization of the gastrointestinal tract
US5310537A (en) * 1993-03-01 1994-05-10 Sterling Winthrop Inc. Compositions of iodoaniline derivatives for visualization of the gastrointestinal tract
US5310538A (en) * 1993-03-11 1994-05-10 Sterling Winthrop Inc. Compositions of iodophenoxy alkylene ethers in film-forming materials for visualization of the gastrointestinal tract
US5344638A (en) * 1993-03-11 1994-09-06 Sterling Winthrop Inc. Compositions of iodobenzoic acid derivatives for visualization of the gastrointestinal tract
US5312616A (en) * 1993-03-11 1994-05-17 Sterling Winthrop Inc. Compositions of iodobenzoic acid derivatives in film-forming materials for visualization of the gastrointestinal tract
US5336484A (en) * 1993-03-31 1994-08-09 Sterling Winthrop Inc. Compositions of iodophenyl esters and iodophenyl sulfonates in film-forming materials for visualization of the gastronintestinal tract
US5318769A (en) * 1993-03-31 1994-06-07 Sterling Winthrop Inc. Compositions of iodophenyl esters for X-ray visualization of the gastrointestinal tract
US5360604A (en) * 1994-04-14 1994-11-01 Sterling Winthrop Inc. X-ray contrast compositions containing an organic crystalline X-ray contrast agent in combination with pharmaceutically acceptable clays

Also Published As

Publication number Publication date
FI964212L (en) 1996-10-18
CN1147206A (en) 1997-04-09
WO1995028969A1 (en) 1995-11-02
EP0756497A1 (en) 1997-02-05
NO964451D0 (en) 1996-10-18
HUT76304A (en) 1997-07-28
JPH09512029A (en) 1997-12-02
MX9604899A (en) 1998-03-31
HU9602908D0 (en) 1996-12-30
AU1897795A (en) 1995-11-16
CA2187019A1 (en) 1995-11-02
FI964212A0 (en) 1996-10-18

Similar Documents

Publication Publication Date Title
EE04578B1 (en) Pharmaceutical composition for oral administration of the N-piperidino-3-pyrazolecarboxamide derivative, its salts and their solvates
AU8296987A (en) Pharmaceutical composition comprising fluticasone propionate
DE69102336D1 (en) Reinforced tubing for medical surgical purposes.
AU2655999A (en) Point of care diagnostic systems
NO20075066L (en) Pharmaceutical composition containing isoflavones
BR0007500A (en) Triazole compound, drug, and, use of the compound
NO910923L (en) TRIFUNCTIONAL ANTIBODY SIMILAR COMPOUND AS A COMBINED DIAGNOSTIC AND THERAPEUTIC AGENT.
ES2177792T3 (en) COMPLEX POLYMERS IN CASCADA, PROCEDURE FOR PREPARATION AND PHARMACEUTICAL AGENTS CONTAINING THEM.
NO964451L (en) X-ray contrast compositions containing pharmaceutically acceptable clays
HUP0002718A2 (en) Piperazine derivatives, process for their preparation and medicaments containing the same
NO163435C (en) PATIENT CHAIR FOR X-ray examinations.
GB9524934D0 (en) Treatment and diagnosis of infections due to helicobacter pylori
EE9900450A (en) Tetrahydropyrido compounds, medicament containing them and their use
MX9302501A (en) RADIOGRAPHIC CONTRAST COMPOSITIONS AND METHODS FOR USE IN VISUALIZATION OF INTESTINAL DUCT
NO965301D0 (en) 2,4,6-Triiod-5-substituted-amino-isophthalate esters useful as X-ray contrast agents for medical diagnostic imaging
ES2024695B3 (en) PROCESS AND DEVICE FOR THE STERILIZATION OF THE NEBULIZATION DUCTS AND / OR AIR SUPPLY OF THE MEDICAL INSTRUMENTS, ESPECIALLY DENTAL SURGERY INSTRUMENTS.
NO963540L (en) X-ray contrast compositions containing cellulose derivatives
IL89335A (en) 6-oxo-pyridazine derivatives, a process for their preparation and pharmaceutical compositions containing these compounds
DE3260703D1 (en) Phenethanol amine derivatives, their preparation and use in medicine
DK0664811T3 (en) Gestagent active 4-estrener with bridge between positions 19,11
NO962248D0 (en) Iodinated biphenyl derivatives and their diagnostic use
NO954695D0 (en) Iodine boron compounds suitable as X-ray contrast agents, and pharmaceutical compounds thereof
SI0790245T1 (en) Substituted Thiophenylalkenylcarbonylguanidide, method for their preparation, their use as medicinal or diagnostic agent as well as medicament containing them
ES2145541T3 (en) NEW SECO-D-STEROIDS ACTIVE ON THE CARDIOVASCULAR SYSTEM, PROCEDURES FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
IL67400A (en) Octahydro-3,7a-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them